Literature DB >> 10918299

Regulation of activin's access to the cell: why is mother nature such a control freak?

D J Phillips1.   

Abstract

Activin A is a pluripotent growth factor with important roles in development, erythropoiesis and the local regulation of many tissues. At the post-translational level, the amount of activin A produced by cells may be modulated through the diversion of activin A subunits into the formation of inhibin or other activins containing heterodimeric forms. Once assembled, activin interacts with various low- and high-affinity binding proteins, such as follistatin and alpha(2)-macroglobulin, that have consequences for receptor availability. In common with other TGFbeta family members, activin signals through pairs of type I and II receptor kinases and the Smad intracellular signalling cascade. Other checkpoints have been identified such as the recently identified pseudoreceptor, BAMBI. These emerging findings point to a tightly coordinated regulation of the exposure of a cell or tissue to activin, consistent with the low amounts of this potent factor that are necessary to modulate cellular responses. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918299     DOI: 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  13 in total

Review 1.  Challenges in the study of neuronal differentiation: a view from the embryonic eye.

Authors:  Ruben Adler
Journal:  Dev Dyn       Date:  2005-11       Impact factor: 3.780

2.  Cripto forms a complex with activin and type II activin receptors and can block activin signaling.

Authors:  Peter C Gray; Craig A Harrison; Wylie Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

3.  Expression of Panza, an alpha2-macroglobulin, in a restricted dorsal domain of the primitive gut in Xenopus laevis.

Authors:  Liliam Pineda-Salgado; Eileen J Craig; Rebecca B Blank; Daniel S Kessler
Journal:  Gene Expr Patterns       Date:  2005-11-07       Impact factor: 1.224

Review 4.  Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.

Authors:  Nader Zamani; Chester W Brown
Journal:  Endocr Rev       Date:  2010-12-20       Impact factor: 19.871

Review 5.  Antagonism of activin by activin chimeras.

Authors:  Uwe Muenster; Radhika Korupolu; Ratindra Rastogi; Jessica Read; Wolfgang H Fischer
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

6.  Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes.

Authors:  Casimir Bamberger; Agnes Schärer; Maria Antsiferova; Birte Tychsen; Sandra Pankow; Mischa Müller; Thomas Rülicke; Ralf Paus; Sabine Werner
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

7.  Weaning and the developmental changes in follicle-stimulating hormone, pituitary adenylate cyclase-activating polypeptide, and inhibin B in the male rat.

Authors:  Joseph P Moore; Stephen J Winters
Journal:  Biol Reprod       Date:  2007-12-26       Impact factor: 4.285

8.  Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1.

Authors:  Brian M Necela; Weidong Su; E Aubrey Thompson
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

9.  Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

Authors:  Tatyana A Souza; Xuan Chen; Yongjing Guo; Parid Sava; Jimin Zhang; Jennifer J Hill; Paul J Yaworsky; Yongchang Qiu
Journal:  Mol Endocrinol       Date:  2008-10-16

10.  Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo.

Authors:  Elspeth Gold; Niti Jetly; Moira K O'Bryan; Sarah Meachem; Deepa Srinivasan; Supreeti Behuria; L Gabriel Sanchez-Partida; Teresa Woodruff; Shelley Hedwards; Hong Wang; Helen McDougall; Victoria Casey; Birunthi Niranjan; Shane Patella; Gail Risbridger
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.